BioVaria

leading biopharmaceutical showcasing event featuring top inventions and startups emerging from public research institutions and universities all over Europe

[BioVaria @BioVaria]

We wish you a Merry Christmas and a relaxing holiday season, enjoy the time with your loved ones!

Your BioVaria Team 🧡 💙

[BioVaria @BioVaria]

#BioVaria2025

We look forward to welcoming you all back to #Munich next year!

In the meantime, don't miss any #Biovaria updates and stay up to date by activating the bell icon in the top-right corner of our profile.

#savethedate #lifesciences #network #innovation

[BioVaria @BioVaria]

Congratulations! 🎉

The #Startup #Award #winners of #BioVaria 2024 are:
🏆QUASAR THERAPEUTICS in the category #Emerging and🏆SurvivX in the category #Rising!

We are looking forward to hearing more about these outstanding projects in the future!

[BioVaria @BioVaria]

And with that #BioVaria 2024 comes to an end! Thank you all for joining and see you again next year! :)

[BioVaria @BioVaria]

The final presentation at #BioVaria2024 is given by Prof. Sangeun Lee from @Saar_Uni. Her presentation on biodynamers enhancing #DrugDelivery will be the conclusion of the fifth presentation stream. Don’t forget to check out poster A3. #BioVaria #Neurodegeneration, #Biomarker

[BioVaria @BioVaria]

Dr. Martin Marek from @MasarykUni continues the presentation stream and shares insights into the coelenterazine-utilizing luciferase #reporters with extremely stable glow-type bioluminescent signal. Check out his poster I5. #BioVaria #Neurodegeneration, #Biomarker #DrugDelivery

[BioVaria @BioVaria]

The next speaker at our #Neurodegeneration, #Biomarker & #DrugDelivery stream is Dr. Mirna Andelic from @NeuroBesta with a presentation about microRNAs as diagnostic biomarkers and therapeutic agents for small fiber neuropathy. Learn more with poster F5. #BioVaria #diagnostics

[BioVaria @BioVaria]

Our next topic is anti-KLK8 against Alzheimer’s disease and Prof. Kathy Keyvani from @unidue will be the one presenting it. Learn more about it at poster P2. #BioVaria #Neurodegeneration, #Biomarker #DrugDelivery

[BioVaria @BioVaria]

The last presentation stream of #BioVaria2024 about #Neurodegeneration, #Biomarker & #DrugDelivery begins and we are happy to start with Prof. Andrea Brancale from @VSCHT introducing a new #treatment for glaucoma. The poster is I6. #BioVaria

[BioVaria @BioVaria]

Join us now for our startup & early-stage innovation award ceremony! #BioVaria 2024

[BioVaria @BioVaria]

lunchbreak at #BioVaria 2024, bon appetit!

[BioVaria @BioVaria]

Join us now for our EPO Lecture on Evolution and patenting of AI in MedTech!
#Biovaria #ExternalLecture

[BioVaria @BioVaria]

And once again, we have reached the end of a presentation stream. Dr. Filippo Spreafico from @IstTumori concludes the stream with his talk on a protective device for subjects with solitary kidney or kidney disease. Check out poster F1. #BioVaria #VascularSystem #PatientCare

[BioVaria @BioVaria]

Dr. Angelica Carandina from Fondazione #IRCCS Ca' Granda Ospedale Maggiore Policlinco with a presentation on highly personalized non-invasive vagus nerve stimulation for the treatment of chronic pain. To find out more, visit poster F4. #BioVaria #VascularSystem #PatientCare

[BioVaria @BioVaria]

Continuing with the vascular simulation device for medical training in eco-guided procedures is Dr. Valeria Mauri from Fondazione #IRCCS Policlinico San Matteo. Learn more about the #techonolgy by visiting poster F3. #BioVaria #VascularSystem #PatientCare #technology

[BioVaria @BioVaria]

P1 We are happy to welcome Dr. Jürgen Walkenhorst from our partner @PROvendis. We can’t wait to learn more about extracorporeal apheresis to treat preeclampsia. You can also visit his poster P1. #BioVaria #VascularSystem #PatientCare

[BioVaria @BioVaria]

Introducing the novel autotaxin inhibitors, Dr. Mathias Eymery from @EMBLGrenoble is here to share some insights. For further information, visit poster E2. #BioVaria #VascularSystem #PatientCare

[BioVaria @BioVaria]

The fourth presentation stream on #VascularSystem & #PatientCare opens with Dr. Dirk Pleimes from Trypto Therapeutics, whose poster is H5. The topic is a novel class of tryptophan hydroxylase-1 inhibitors to address unmet medical needs in serotonin-dependent diseases. #BioVaria

[BioVaria @BioVaria]

Welcome to the #beergarden @BioVaria 2024! Enjoy the evening!